Prevalence of Osteoporosis in Korean Prostate Cancer Patients Who is Receiving LHRH Agonist and/or Anti-androgen Agent

Clinical trial NCT01025479 · COMPLETED

Trial details

NCT number: NCT01025479
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Prostate Cancer Osteoporosis

Start date: 2009-11-01
Primary completion: 2010-03-01
Enrollment: 829

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.